Sex-specific effects of spironolactone on blood pressure in gonadectomized male and female wistar rats

Hormone and Metabolic Research

Volumn 44, Issue 4, 2012, Pages 291-295

  Michaelis, M ^a,b   Hofmann, P J ^a   Gotz F ^a   Bartel, C ^a   Kienitz, T ^a   Quinkler, M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b LEIBNIZ INSTITUTE FOR FARM ANIMAL BIOLOGY FBN   (Germany)

Author keywords

aldosterone; high and low salt diet; hypertension; mineralocorticoid receptor antagonist; sex difference; spironolactone

Indexed keywords

ALDOSTERONE; SODIUM CHLORIDE; SPIRONOLACTONE;

ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD SAMPLING; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GONADECTOMY; KIDNEY MASS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SEX; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE; URINALYSIS; URINE; WISTAR RAT;

ALDOSTERONE; ALDOSTERONE ANTAGONISTS; ANIMALS; BLOOD PRESSURE; FEMALE; GONADS; HUMANS; HYPERTENSION; MALE; ORCHIECTOMY; OVARIECTOMY; RATS; RATS, WISTAR; RECEPTORS, MINERALOCORTICOID; SEX FACTORS; SPIRONOLACTONE;

ANIMALIA; RATTUS; RATTUS NORVEGICUS; RODENTIA;

EID: 84859363151     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0031-1299774     Document Type: Article

References (22)

1. Freis E D. Salt, volume and the prevention of hypertension. Circulation: 1976; 53 589 594
2. Meneely G R, Battarbee H D. High sodium-low potassium environment and hypertension. Am J Cardiol: 1976; 38 768 785 (Pubitemid 8005692)
3. He F J, MacGregor G A. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens: 2002; 16 761 770 (Pubitemid 36007929)
4. Law M R, Frost C D, Wald N J. By how much does dietary salt reduction lower blood pressure? III - Analysis of data from trials of salt reduction. BMJ: 1991; 302 819 824
5. Sacks F M, Svetkey L P, Vollmer W M, Appel L J, Bray G A, Harsha D, Obarzanek E, Conlin P R, Miller E R, Simons-Morton D G, Karanja N, Lin P H. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med: 2001; 344 3 10 (Pubitemid 32064838)
6. Calhoun D A, Zhu S, Wyss J M, Oparil S. Diurnal blood pressure variation and dietary salt in spontaneously hypertensive rats. Hypertension: 1994; 24 1 7 (Pubitemid 24195397)
7. Harshfield G A, Alpert B S, Pulliam D A, Somes G W, Wilson D K. Ambulatory blood pressure recordings in children and adolescents. Pediatrics: 1994; 94 180 184 (Pubitemid 24236137)
8. Himmelmann A, Svensson A, Hansson L. Influence of sex on blood pressure and left ventricular mass in adolescents: the Hypertension in Pregnancy Offspring Study. J Hum Hypertens: 1994; 8 485 490 (Pubitemid 24222551)
9. Wiinberg N, Hoegholm A, Christensen H R, Bang L E, Mikkelsen K L, Nielsen P E, Svendsen T L, Kampmann J P, Madsen N H, Bentzon M W. 24-h ambulatory blood pressure in 352 normal Danish subjects, related to age and gender. Am J Hypertens: 1995; 8 978 986
10. Yong L C, Kuller L H, Rutan G, Bunker C. Longitudinal study of blood pressure: changes and determinants from adolescence to middle age. The Dormont High School follow-up study, 1957-1963 to 1989-1990. Am J Epidemiol: 1993; 138 973 983 (Pubitemid 24002363)
11. Reckelhoff J F. Gender differences in the regulation of blood pressure. Hypertension: 2001; 37 1199 1208 (Pubitemid 34163570)
12. Reckelhoff J F, Granger J P. Role of androgens in mediating hypertension and renal injury. Clin Exp Pharmacol Physiol: 1999; 26 127 131
13. Khalid M, Ilhami N, Giudicelli Y, Dausse J P. Testosterone dependence of salt-induced hypertension in Sabra rats and role of renal alpha(2)-adrenoceptor subtypes. J Pharmacol Exp Ther: 2002; 300 43 49 (Pubitemid 34028506)
14. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med: 2003; 348 1309 1321 (Pubitemid 36384098)
15. Pitt B, Zannad F, Remme W J, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med: 1999; 341 709 717 (Pubitemid 29407370)
16. Caplea A, Seachrist D, Dunphy G, Ely D. Sodium-induced rise in blood pressure is suppressed by androgen receptor blockade. Am J Physiol Heart Circ Physiol: 2001; 280 H1793 H1801
17. Gerhold D, Bagchi A, Lu M, Figueroa D, Keenan K, Holder D, Wang Y, Jin H, Connolly B, Austin C, Onso-Galicia M. Androgens drive divergent responses to salt stress in male versus female rat kidneys. Genomics: 2007; 89 731 744 (Pubitemid 46719794)
18. Kienitz T, Allolio B, Strasburger C J, Quinkler M. Sex-specific regulation of ENaC and androgen receptor in female rat kidney. Horm Metab Res: 2009; 41 356 362
19. Yanes L L, Sartori-Valinotti J C, Iliescu R, Romero D G, Racusen L C, Zhang H, Reckelhoff J F. Testosterone-dependent hypertension and upregulation of intrarenal angiotensinogen in Dahl salt-sensitive rats. Am J Physiol Renal Physiol: 2009; 296 F771 F779
20. Quan A, Chakravarty S, Chen J K, Chen J C, Loleh S, Saini N, Harris R C, Capdevila J, Quigley R. Androgens augment proximal tubule transport. Am J Physiol Renal Physiol: 2004; 287 F452 F459 (Pubitemid 39095959)
21. Rahmouni K, Barthelmebs M, Grima M, Imbs J L, de Jong W. Cardiovascular and renal effects of central administration of a mineralocorticoid receptor antagonist in conscious female rats. Eur J Pharmacol: 1999; 385 199 202
22. Rigsby C S, Burch A E, Ogbi S, Pollock D M, Dorrance A M. Intact female stroke-prone hypertensive rats lack responsiveness to mineralocorticoid receptor antagonists. Am J Physiol Regul Integr Comp Physiol: 2007; 293 R1754 R1763 (Pubitemid 47535795)